Introduction: Non-alcoholic fatty liver disease (NAFLD) is a distinct clinicopathologic entity characterized histologically by a spectrum ranging from simple steatosis to steatohepatitis (NASH), cirrhosis and even hepatocellular carcinoma (HCC).
Introduction:
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in Western countries. [1] [2] [3] It is often linked to obesity and the presence of metabolic syndrome (MS). NAFLD is a distinct clinicopatho-logic entity characterized histologically by a spectrum ranging from simple steatosis to steatohepatitis (NASH), cirrhosis and even hepatocellular carcinoma (HCC). 1.4.5 With the introduction of westernized lifestyle and the increasing frequencies of obesity in the Asia-Pacific region, the prevalence of NAFLD has increased over the past two decades. [6] [7] [8] [9] NAFLD has widely been considered a manifestation of metabolic syndrome in close relation to obesity [10] [11] .
Materials and Methods:
It was a cross sectional study done in Department of gastroenterology, Nuclear Medicine and ultrasound, Radiology and Imaging, Virology, Biochemistry BSMMU, Dhaka from March 2012 to June 2014. Patients attending in inpatient and outpatient department of Gastroenterology, BSMMU were enrolled for the study. The patients were more or equal to 18 years, non-obese [BMI (Body mass index) < 25] and gave consent for participating the study procedure. But the patients who were obese and consumed any amount of alcohol were not included. Subjects with the above criteria were sent for investigations for determination of risk factors of NAFLD by using the data collection form. The research was approved by the Ethical Review Committee of BSMMU, Dhaka. Data from the study was analyzed using SPSS (version 20) program. 
Results: Demographic characteristics

Conclusion
This is a small scale study based on the patients attending into tertiary centre, BSMMU. Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder originally assumed to be largely confined to residents of affluent, industrialized Western countries.In particular, there has been an upsurge in obesity-related metabolic syndrome in Asia-Pacific region. In this study, 20% patients had NAFLD on ultrasound finding which is very similar to the study of India, Southeast Asia and even in some western countries. Sedentary life style, Metabolic syndrome, DM, dyslipidameia, are risk factors of NAFLD in non obese person. Elevated liver enzymes are consequences of NAFLD. Though this study has some limitations, it will give some information about emerging liver disease without viral hepatitis. As NAFLD number in nonobese person is increasing day by day, further study may be conducted to explore more information.
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